Brown, Janet http://orcid.org/0000-0003-4960-3032
Harrow, Brooke
Marciniak, Anne
McCarthy, Christine
Houchard, Aude
Cirneanu, Lori
Protheroe, Andrew
Clinical trials referenced in this document:
Documents that mention this clinical trial
Cabozantinib and Axitinib After Vascular Endothelial Growth Factor Therapy in Patients with Advanced Renal Cell Carcinoma: A Retrospective Cohort Study from England
https://doi.org/10.1007/s40801-023-00415-w
Funding for this research was provided by:
Ipsen
Article History
Accepted: 21 December 2023
First Online: 24 January 2024
Declarations
:
: The study was sponsored by Ipsen. The sponsor played a role in the design and conduct of the study; management, analysis, and interpretation of the data; and preparation, review, and approval of the manuscript. Medical writing support was sponsored by Ipsen in accordance with Good Publication Practice guidelines.
: Janet Brown has received research grants (to institution) from Amgen and AstraZeneca, and advisory board/speaker honoraria from Amgen, Bayer, Bristol Myers Squibb, Daiicho-Sankyo, Ipsen, MSD, Novartis, and Sandoz, and conference travel expenses from Ipsen. Brooke Harrow is a former employee of Ipsen. Anne Marciniak is a former employee (consultant) of Ipsen and an employee of Adelphi Values PROVE, and has shareholder/stockholder/stock options in Abbvie, Amgen, Pfizer, and Viatris. Christine McCarthy is a former employee (consultant) of Ipsen and an employee (consultant) for Inversago Pharma, and has shareholder/stockholder/stock options in Sanofi. Aude Houchard is an employee of Ipsen and has shareholder/stockholder/stock options in Ipsen. Lori Cirneanu is an employee of IQVIA. Andrew Protheroe has received advisory board honoraria from Astellas, Bristol Myers Squibb, Ipsen, Merck, and MSD, and speaker fees from Eisai.
: The study was conducted in accordance with the principles of the World Medical Association Declaration of Helsinki and the International Conference on Harmonisation Good Clinical Practice and Good Epidemiology Practice. No specific patient consents or ethical approvals were required.
: Not applicable.
: Not applicable.
: Restrictions apply to the availability of these data because the data underlying this publication were provided by IQVIA (London, UK) under contract to Ipsen.
: Not applicable.
: LC had full access to all the data in this study and takes responsibility for data acquisition, the integrity of the data, and the accuracy of the data analysis. BH contributed to the study concept and design. BH, AM, CM, AH, and LC performed the statistical analysis. All authors contributed to the analysis and interpretation of the data, drafting the manuscript, critical revision of the manuscript for important intellectual content, and read and approved the final version of the manuscript for publication.